NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Leukemia & Lymphoma Society

Leukemia & Lymphoma Society

Rye Brook, New Yorklls.org

Overview

The Leukemia & Lymphoma Society (LLS) is a voluntary health organization dedicated to curing leukemia, lymphoma, Hodgkin's disease and myeloma, and to improving the quality of life of patients and their families . LLS funds blood cancer research, provides free information and support services, and advocates for blood cancer patients and their families seeking access to quality and affordable care .

Year Founded

1949

Portfolio Companies

3

Website

lls.org

Investments

Leukemia & Lymphoma Society investments
CompanyDateStageLead
Immune-Onc TherapeuticsJan 2023Series B Extension-
Abintus BioAug 2022Series BCo-investor
Immune-Onc TherapeuticsMar 2021Series B-
OncoPep, Inc.Aug 2014Series BCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersRye Brook, New York
Year Founded1949

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.